~~<i id='B08259C448'><strike id='B08259C448'><tt id='B08259C448'><pre id='B08259C448'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：Wikipedia 2025-09-06 07:41:27 Page View：31

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Noem? Reynolds? A very early look at the Republican 'veepstakes'
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

ResidentsoftheJeninrefugeecampfledtheirhomesastheIsraelimilitarypressedaheadwithanoperationinthearea

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

RoriChangholdsmicrochipinformationaftergettingherdogAvamicrochippedattheMaricopaCountryAnimalCare&Co